Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05495256 · ClinicalTrials.gov registry record · NA
Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.
A NA study of Asthma and COPD, sponsored by Pulmonary Critical Care Associates of Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05495256 is a NA study of Asthma and COPD that has completed, run by Pulmonary Critical Care Associates of Baltimore. The registered enrollment target is 74 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05495256, a NA study of Asthma and COPD, has completed, sponsored by Pulmonary Critical Care Associates of Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
To Determine whether use of the Respimetrix flow test device a) can determine "good" versus "poor" inhaler techniques, and b) the effects of the inhaler training on technique.
Interventions
- DEVICE Respimetrix
Study Locations (1)
Maryland
- Pulmonary and Critical Care Associates Of Baltimor - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05495256
The ClinicalTrials.gov registry entry for NCT05495256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The listed sponsor is Pulmonary Critical Care Associates of Baltimore, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Respimetrix is the first listed.
NCT05495256 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05495256 about?
NCT05495256 is a clinical study titled "Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.". To Determine whether use of the Respimetrix flow test device a) can determine "good" versus "poor" inhaler techniques, and b) the effects of the inhaler training on technique.
What is the current status of trial NCT05495256?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2021-05-01. Estimated completion is 2022-03-22.
What conditions does trial NCT05495256 study?
This clinical trial studies the following conditions: Asthma, COPD.
What interventions are being tested in trial NCT05495256?
The interventions under investigation include: Respimetrix (DEVICE).
Who is sponsoring clinical trial NCT05495256?
This trial is sponsored by Pulmonary Critical Care Associates of Baltimore, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05495256 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.